Author Archive: BIOtechNOW Editor

Riding Coast to Coast for Cancer Patients

patient-summit-4

For 21 days in September, 80 members of Bristol-Myers Squibb’s (BMS) oncology team will cross the United States, from the Oregon coast to the New Jersey shore, as part of the third annual Coast 2 Coast 4 Cancer ride. The goal is to raise one million dollars for Stand Up To Cancer, whose collaborative “Dream Teams” of scientific researchers are working together to accelerate cancer research and provide innovative treatment to patients faster. At the Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , ,

All Pharma Wants to Be “Patient-Centric” – What Does That Really Mean?

patient-summit-4

The concept “patient-centricity” has become a pharmaceutical industry buzzword in recent years, making it difficult to see how this concept translates into meaningful practice. Most organizations work for the benefit of patients, but infusing the patient needs and opinions into the discovery, development and delivery of medicines requires a different level of commitment. For Takeda Oncology, that commitment spans nearly two decades, beginning before the company even launched its first product in oncology. From the Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , ,

Animal Agriculture: An Industry Striving for Perfection and Committed to Continuous Improvement

Field

I have always been a perfectionist when it comes to my work, so it’s no surprise I found my passion in an industry that also strives for perfection. Animal agriculture never stops reaching for the highest quality of animal care, environmental stewardship and food safety possible. The industry strives for perfection, but also knows that perfection is hard to come by in agriculture because farmers, ranchers, veterinarians and all those involved in the farm-to-fork process Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , , ,

PTAB, IPRs and Uncertainty in the Patent System

shutterstock_26191726

The topic of inter partes reviews (IPRs) has dominated conversation in patent circles for the last several years (see our archive for some of our past articles on the subject). As uncertainty grows in the biopharma community about IPR procedures and the future of innovation, BIO will make IPRs a major topic of discussion at our upcoming IP and Diagnostics Symposium (BIO IPDX) as well as BIO’s IP Counsels Committee Meeting in November. An administrative Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , ,

Challenging Entrepreneurs to Heal the World

shutterstock_26191726

The healthcare industry needs a refresh! Through improvements in medicine, sanitation and general living conditions, we’ve made great strides at fighting many of the maladies that have plagued humanity for centuries, lowering child mortality rates while increasing life spans by decades. Yet as a consequence of living longer, we’re facing new health issues and the increasing prevalence of chronic conditions and , neurodegenerative,  metabolic and immunological diseases. Despite scientific advancements in many fields, insufficient progress Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , ,